04/12/2025 - Press release
A study from the Hospital del Mar Research Institute, published in The Journal of Clinical Investigation, indicates that the high expression of the estrogen receptor is the main factor preventing the most common type of breast cancer, luminal breast cancer, from responding to immunotherapy. The high presence of the estrogen receptor sequesters the LCOR molecule, whose action on tumor cells is necessary to make tumors visible to the immune system. In experimental models, the researchers found that combining immunotherapy with endocrine therapy allows LCOR to function and the immune system to attack the tumor. At the same time, they have generated a modified version of the LCOR molecule that sensitizes tumors to immunotherapy, including those with hormone receptors. The next goal is to study this molecule combined with immunotherapy in clinical trials.
25/11/2025 - Institutional news
Dr. César Jessé Enríquez has received the award for the best oral presentation in the area of the CIBER of Respiratory Diseases (CIBERES) during the Joint Training Days between the CIBER area of Respiratory Diseases (CIBERES) and the CIBER area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), focused on early-career researchers. The event took place at Euroforum El Escorial on November 6 and 7.
Més informació "Award for César Jessé Enríquez at the joint training days of CIBER-BBN and CIBERES"
24/11/2025 - General information
The new edition of the Highly Cited Researchers ranking, produced by Clarivate, has selected 6,868 researchers worldwide who have demonstrated significant influence in their research fields over the past eleven years. Two researchers from the Hospital del Mar Research Institute, Dr Jordi Alonso and Dr Joaquim Bellmunt, are once again included in the ranking. The researchers featured in the ranking work across around sixty countries. The United States leads the list, followed by China and the United Kingdom. Only around ninety of the selected researchers work in institutions in Spain.
21/11/2025 - Institutional news
A project aimed at advancing knowledge of the tumour microenvironment in colon and rectal cancer in order to identify new therapeutic strategies, led by Dr Alexandre Calon, coordinator of the Translational Research Group in Tumour Microenvironment at the Hospital del Mar Research Institute, is one of those selected in the latest Health Research Call of the "la Caixa" Foundation. The proposal will receive nearly one million euros to seek solutions to the challenge of treatment resistance in this type of tumour.
20/11/2025 - Press release
This discovery, carried out by a multidisciplinary team led by researchers from the Hospital del Mar Research Institute and the Sant Joan de Déu Research Institute, opens the door to understanding the mechanisms that trigger tumour proliferation and to exploring potential therapeutic targets. Researchers suspect that the genetic alteration that activates the mechanisms behind this type of cancer occurs during embryonic development. Ewing sarcoma is a highly aggressive tumour that can affect bones and soft tissues, and is the most frequent bone tumour in childhood.
Més informació "Researchers identify the cell of origin of Ewing Sarcoma"
19/11/2025 - Events
Dr. María Martínez, Head of the Neuro-oncology Section at Hospital del Mar and researcher at the Hospital del Mar Research Institute, has been elected as a new member of the Board of Directors of the Spanish Society of Medical Oncology (SEOM), following the vote held during the SEOM2025 congress. The vote served to partially renew the organisation's governing body, with the candidacy led by Dr. Antonio González, from the Clínica Universidad de Navarra, elected as the new vice-president of the Board.
18/11/2025 - General information
Solidarity, through La Marató de 3Cat, continues to drive research. The 10 million euros raised in the latest edition, dedicated to respiratory diseases, will be used to fund 36 research projects from sixty research groups. Among them are two projects led by researchers from the Hospital del Mar Research Institute and Hospital del Mar. One of the projects, led by Dr. Joan Ramon Masclans, head of the Intensive Care Medicine Service at Hospital del Mar and coordinator of the Critical Illness Research Group at the HMRIB, will focus on predicting treatment response in patients with acute hypoxemic respiratory failure treated with high-flow nasal cannula, using omics and clinical data. To do so, they will receive nearly 300,000 euros. The project also involves the Institute for Bioengineering of Catalonia (IBEC).
17/11/2025 - General information
Dr José Yélamos López has received the Carmen Delgado/Miguel Pérez Mateo Grant in the basic research category. The award ceremony for the grant, worth 100,000 euros, took place on 5 November. These grants are awarded by the Pancreatic Cancer Association, in collaboration with the Spanish Association of Pancreatology and the Spanish Association of Gastroenterology, with the aim of promoting basic and clinical research in pancreatic cancer. They are made possible thanks to the public's participation in the Carrera de las Ciudades contra el Cáncer de Páncreas (Cities Race Against Pancreatic Cancer), which in 2025 reached its tenth edition.
Més informació "Carmen Delgado/Miguel Pérez Mateo Grant for Dr José Yélamos López"
12/11/2025 - Institutional news
Dr. Xavier Nogués, Dr. Gloria Nohales, and Dr. Antoni Payà are three of the professionals who will receive, on December 1, one of the Professional Excellence Prizes awarded by the Col·legi de Metges de Barcelona. These distinctions acknowledge their career achievements and will be presented at a ceremony held at the Axa Auditorium in L'Illa Diagonal. The Professional Excellence Prizes of the Col·legi de Metges de Barcelona (COMB) are awarded to physicians in recognition of careers distinguished by commitment, honesty, altruism, integrity, and excellence. The awards are given in the fields of primary care medicine, hospital care medicine, medicine in other healthcare settings, biomedical research, medical education and training, and the humanities, cooperation, and management. The 2025 edition marks their 21st year.
11/11/2025 - General information
Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has just joined the journal Development as an Associate Editor. The journal is published by The Company of Biologists, a non-profit organization led by leading scientists in the field. This is one of the reference publications in its area. Dr. Bigas will be responsible for evaluating and deciding on the publication of studies related to the development of hematopoietic stem cells and how their deregulation contributes to the onset of blood diseases.
Més informació "Dr. Anna Bigas begins a new chapter as Associate Editor of the journal Development"
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
